We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
+21.12%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$527K
AUM Growth
-$461M
Cap. Flow
-$198M
Cap. Flow %
-37,549.24%
Top 10 Hldgs %
85.67%
Holding
53
New
24
Increased
3
Reduced
3
Closed
11

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$204M
2
RTX icon
RTX Corp
RTX
+$62.4M
3
ASH icon
Ashland
ASH
+$16.5M
4
QGEN icon
Qiagen
QGEN
+$11.2M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$8.34M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.1%
2 Industrials 12.33%
3 Materials 9.37%
4 Financials 6.94%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$300B
$238K 45.1%
+2,278
New +$474K
TIF
2
DELISTED
Tiffany & Co.
TIF
$58.1K 11.02%
478,155
+289,406
+153% +$36.2M
CSTM icon
3
Constellium
CSTM
$4B
$49.4K 9.37%
6,363,674
+1,636,645
+35% +$11.9M
GRUB
4
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$42.2K 8.01%
305,694
-54,472
-15% -$5.77M
OTIS icon
5
Otis Worldwide
OTIS
$28.2B
$14.7K 2.79%
+262,203
New +$13.6M
GLIBA
6
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$13.5K 2.55%
+191,026
New +$12.2M
OSG
7
Octave Specialty Group
OSG
$210M
$12K 2.28%
+844,500
New +$12.3M
THBR
8
DELISTED
Thunder Bridge Acquisition II, Ltd. Class A Ordinary Shares
THBR
$8.06K 1.53%
800,000
BKSY icon
9
BlackSky Technology
BKSY
$1.3B
$8K 1.52%
100,000
SRTA
10
Strata Critical Medical Inc
SRTA
$533M
$7.92K 1.5%
800,000
IPOC.U
11
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
$7.77K 1.47%
+650,000
New +$6.95M
GNOG
12
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$7.17K 1.36%
451,800
-200,100
-31% -$2.03M
WPF.U
13
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
$6.42K 1.22%
+600,000
New +$6.28M
SCPE
14
DELISTED
SC Health Corporation
SCPE
$6.07K 1.15%
+600,000
New +$5.99M
ALUS
15
DELISTED
Alussa Energy Acquisition Corp
ALUS
$5.37K 1.02%
550,000
JWS.U
16
DELISTED
Jaws Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one red
JWS.U
$5.25K 1%
+500,000
New +$5.2M
CTEV
17
Claritev Corp
CTEV
$599M
$5.23K 0.99%
+12,500
New +$5.04M
UWMC icon
18
UWM Holdings
UWMC
$2.42B
$5.04K 0.96%
+500,000
New +$4.99M
HIMS icon
19
Hims & Hers Health
HIMS
$6.99B
$4.08K 0.77%
400,000
TREB.U
20
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$3.67K 0.7%
+350,000
New +$3.64M
OPEN icon
21
Opendoor
OPEN
$3.39B
$3.14K 0.6%
+277,450
New +$3.04M
ASTS icon
22
AST SpaceMobile
ASTS
$22.2B
$3.03K 0.57%
300,000
SKIL icon
23
Skillsoft
SKIL
$78.7M
$2.22K 0.42%
+10,000
New +$2.09M
TMUS icon
24
T-Mobile US
TMUS
$190B
$1.85K 0.35%
+64,350
New +$6.17M
ADV icon
25
Advantage Solutions
ADV
$399M
$1.66K 0.32%
6,000

Similar funds

Boussard & Gavaudan Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boussard & Gavaudan Investment Management held 53 positions worth $527K, down 100% from $461M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $198M in Q2 2020, closing 11 positions and reducing 3 holdings. Its most notable exit was Allergan plc, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, up from 0% a quarter earlier, followed by Industrials and Materials.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in Otis Worldwide worth $14.7K.

  • Boussard & Gavaudan Investment Management's largest Q2 2020 buy was Otis Worldwide: 262,203 shares worth $14.7K.
  • Boussard & Gavaudan Investment Management added most to Tiffany & Co. in Q2 2020, an estimated $36.2M increase.
  • Boussard & Gavaudan Investment Management's biggest Q2 2020 reduction was Qiagen, cutting an estimated $11.2M.
  • Boussard & Gavaudan Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $204M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 86% of its $527K portfolio in Q2 2020.
  • Boussard & Gavaudan Investment Management opened 24 new positions and closed 11 in Q2 2020.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $527K.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.